IP Library › Granted Patent US 11,839,418
Granted Patent B2
US 11,839,418 · App. 17/022,080 · Granted Dec 12, 2023

Device and method for lung treatment

Inventors: Robert L. Barry (Kirkland, WA); Brian Cran (Seattle, WA); Dean T. Corcoran (Seattle, WA); Sheldon K. Lee (Seattle, WA)
Assignee: Uptake Medical Technology Inc.
A61B18/04A61B1/2676A61B8/08A61M16/14A61M31/005A61N7/022A61B2017/00106A61B2018/00285A61B2018/00541A61B2018/00571A61B2018/00994A61B2018/048A61B2218/002A61B2218/007A61M2210/1039A61N2007/0004
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,839,418
App. No.
17/022,080
Filed
Sep 16, 2020
Granted
Dec 12, 2023
Kind
B2
Art Unit
3792
USPC
601/3
Abstract

This invention relates to the treatment of a patient's lung, for example, a lung exhibiting chronic obstructive pulmonary disease (COPD) and in particular to methods and devices for affecting lung volume reduction, preferably for achieving acute or immediate lung volume reduction following treatment. The lung volume reduction is effected by delivering a condensable vapor at a temperature above body temperature to the desired regions of the patient's lung to damage tissue therein. Blood flow and air flow to the damaged tissue region is essentially terminated, rendering the target region non-functional. Alternative energy sources may be used to effect the thermal damage to the lung tissue.

Claims (17)

1. A method for ablating a lung nodule comprising:

navigating a vapor delivery catheter to a location proximal a targeted region encompassing the lung nodule; and

delivering a condensable vapor from the delivery catheter into the targeted region sufficient to ablate the lung nodule, wherein the condensable vapor is delivered at a temperature of at least 40 degrees C. and between 5 seconds and 10 minutes.

2. The method of claim 1 wherein the step of delivering comprises delivering a predetermined amount of the condensable vapor to the targeted region.

3. The method of claim 2 wherein the predetermined amount of condensable vapor comprises a biocompatible dye.

4. The method of claim 3 further comprising detecting or monitoring the ablation by visually observing the dye moving in the targeted region.

5. The method of claim 1 , further comprising applying a focused ablation energy to the targeted region.

6. The method of claim 5 , wherein the focused ablation energy comprises HIFU.

7. The method of claim 6 , further comprising occluding an airway proximal to the area where the condensable vapor is delivered and such that the condensable vapor flows throughout the targeted region.

8. The method of claim 7 , wherein the targeted region comprises segmental bronchi and sub-segmental bronchi.

9. The method of claim 1 , further comprising delivering a patient preparation medication into the targeted region via said delivery catheter before delivering the condensable vapor.

10. The method of claim 9 , wherein the patient preparation medication is a pain-killer or numbing substance.

11. The method of claim 1 , wherein the lung nodule is cancerous.

12. The method of claim 1 , comprising applying RF ablation to the targeted region.

13. The method of claim 12 , further comprising delivering a conductive fluid to the targeted region for effective ablation.

14. The method of claim 1 , further comprising applying vacuum to the targeted region.

15. The method of claim 1 , wherein the condensable vapor is delivered at a temperature between 50 and 60 degrees C.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2020
From: BARRY, ROBERT; CRAN, BRIAN; CORCORAN, DEAN
To: UPTAKE MEDICAL CORP.
Reel/Frame 054679/0246 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2020
From: LEE, SHELDON K
To: UPTAKE MEDICAL CORP.
Reel/Frame 054679/0323 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2020
From: UPTAKE MEDICAL CORP.
To: UPTAKE MEDICAL TECHNOLOGY INC.
Reel/Frame 054679/0437 →
Continuity (7)
Continuation 15582765 · Apr 30, 2017
Continuation 14703580 · May 4, 2015
Division 13073660 · Mar 28, 2011
Continuation 11281212 · Nov 16, 2005
Provisional Application 60648036 · Jan 27, 2005
Provisional Application 60628451 · Nov 16, 2004
Related Publication 20210000524A1 · Jan 7, 2021